
This consultation closed on 22 March 2019
Invitation to comment
The Office of Drug Control sought comments from interested parties on the options concerning the announcement by the Prime Minister, the Hon Scott Morrison MP, to put together a pilot program to ease some of the limitations on importation of kava into Australia for personal use.
The consultation sought feedback on:
- A proposal to increase the quantity of kava that may be imported for personal use to 4kg
- Approach to evaluate the pilot program after two years; and
- The duration of the pilot program.
Consultation documents
Timetable
Interested parties should respond by close of business 22 March 2019.
Feedback will be released following consideration of submissions. (See 'What will happen').
About the consultation
On the 16 January 2019, the Prime Minister announced a pilot program would be put together to ease some of the restrictions on importation of kava, for personal use, into Australia.
The consultation paper has been prepared to enable interested parties to provide feedback on the pilot.
Content of submissions
Submissions may address any, or all, of the Pilot Program to ease restrictions on the importation of kava for personal use, or other identified issues.
In addition, submissions might include:
- Suggested improvements.
- Whether or not you support the proposal, including suggestions for alternatives.
- An assessment of how the proposal will affect you.
Enquiries
Any questions relating to submissions should be directed to the Drug Control Section by email to dcs@health.gov.au.
What will happen
All submissions will be placed on this website unless marked confidential or indicated otherwise in the submission form (see Privacy information).
The feedback on the consultation paper will be used to inform decisions on the pilot plan to ease some of the limitations on importation of kava into Australia for personal use.
Privacy information
- The ODC collects your personal information in this submission in order to:
- contact you if the ODC wants to seek clarification of issues raised in your submission or to check whether you consent to certain information that you have provided being made publicly available.
- help provide context about your submission (e.g. to determine whether you are an individual or a director of a company or representing an interest group).
- seek feedback about how the consultation was undertaken.
- Please do not include personal information about other individuals in the body of your submission. Personal information in this context means information or an opinion about an individual whose identity is apparent, or can reasonably be ascertained, from the information or opinion.
- More information on privacy can be found on our website.
Submissions received
A
- Consultation submission: Aboriginal Medical Services Alliance NT (PDF 187KB)
- Consultation submission: Aboriginal Resource and Development Services (PDF 127KB)
- Consultation submission: Anonymous 1 (PDF 67KB)
- Consultation submission: Anonymous 2 (PDF 34KB)
- Consultation submission: Anonymous 3 (PDF 34KB)
- Consultation submission: Anonymous 4 (PDF 33KB)
- Consultation submission: Anonymous 5 (PDF 15KB)
- Consultation submission: Anonymous 6 (PDF 77KB)
- Consultation submission: Anonymous 7 (PDF 93KB)
- Consultation submission: Anonymous 8 (PDF 27KB)
- Consultation submission: Anonymous 9 (PDF 34KB)
- Consultation submission: Anonymous 10 (PDF 37KB)
- Consultation submission: Anonymous 11 (PDF 34KB)
- Consultation submission: Anonymous 12 (PDF 33KB)
- Consultation submission: Anonymous 13 (PDF 36KB)
- Consultation submission: Anonymous 14 (PDF 35KB)
- Consultation submission: Anonymous 15 (PDF 68KB)
- Consultation submission: Anonymous 16 (PDF 35KB)
- Consultation submission: Anonymous 17 (PDF 34KB)
- Consultation submission: Anonymous 18 (PDF 73KB)
- Consultation submission: Anonymous 19 (PDF 63KB)
- Consultation submission: Anonymous 20 (PDF 33KB)
- Consultation submission: Anonymous 21 (PDF 36KB)
- Consultation submission: Anonymous 22 (PDF 78KB)
- Consultation submission: Anonymous 23 (PDF 36KB)
- Consultation submission: Anonymous 24 (PDF 36KB)
- Consultation submission: Anonymous 25 (PDF 34KB)
- Consultation submission: Anonymous 26 (PDF 36KB)
- Consultation submission: Anonymous 27 (PDF 35KB)
- Consultation submission: Anonymous 28 (PDF 72KB)
- Consultation submission: Anonymous 29 (PDF 200KB)
- Consultation submission: Anonymous 30 (PDF 48KB)
- Consultation submission: Anonymous 31 (PDF 35KB)
- Consultation submission: Anonymous 32 (PDF 42KB)
- Consultation submission: Dr S Apo Aproosa (PDF 256KB)
B
- Consultation submission: Biosecurity Authority Fiji (PDF 173KB)
- Consultation submission: Brisbane Tongan Community Inc. (PDF 1.34MB)
C
F
G
H
L
- Pulotu Lyndon Chu Ling, Chief Executive Office National Codex Committee, Ministry of Commerce, Industry and Labour Samoa
M
- Consultation submission: Feloko a Maui (PDF 791KB)
- Consultation submission: Ministry for Agriculture Fiji (PDF 192KB)
- Consultation submission: Ministry of Commerce Industry and Labour (PDF 348KB)
N
- Consultation submission: National Drug Research Institute (PDF 736KB)
- Consultation submission: Northern Territory Council of Social Service (PDF 184KB)
P
- Consultation submission: Dr Haunga Petelo (PDF 10KB)
- Ardimulam Pillay, Medical Practitioner
S
- Consultation submission: Jitoko Sisaro (PDF 47KB)
- Professor Jerome Sarris, NICM Health Research Institute, Western Sydney University